Atnaujinkite slapukų nuostatas

Ending Neglect: The Elimination of Tuberculosis in the United States [Kietas viršelis]

  • Formatas: Hardback, 292 pages, aukštis x plotis: 229x152 mm
  • Išleidimo metai: 01-Oct-2000
  • Leidėjas: National Academies Press
  • ISBN-10: 0309070287
  • ISBN-13: 9780309070287
Kitos knygos pagal šią temą:
  • Formatas: Hardback, 292 pages, aukštis x plotis: 229x152 mm
  • Išleidimo metai: 01-Oct-2000
  • Leidėjas: National Academies Press
  • ISBN-10: 0309070287
  • ISBN-13: 9780309070287
Kitos knygos pagal šią temą:
Tuberculosis emerged as an epidemic in the 1600s, began to decline as sanitation improved in the 19th century, and retreated further when effective therapy was developed in the 1950s. TB was virtually forgotten until a recent resurgence in the U.S. and around the worldominously, in forms resistant to commonly used medicines.



What must the nation do to eliminate TB? The distinguished committee from the Institute of Medicine offers recommendations in the key areas of epidemiology and prevention, diagnosis and treatment, funding and organization of public initiatives, and the U.S. role worldwide. The panel also focuses on how to mobilize policy makers and the public to effective action.



The book provides important background on the pathology of tuberculosis, its history and status in the U.S., and the public and private response.



The committee explains how the U.S. can act with both self-interest and humanitarianism in addressing the worldwide incidence of TB.

Table of Contents



Front Matter Executive Summary 1 Fundamentals of Tuberculosis and Tuberculosis Control 2 The Current Situation and How We Got Here 3 Tuberculosis Elimination and the Changing Role of Tuberculosis Control Programs 4 Advancing Toward Elimination 5 Developing the Tools for Tuberculosis Elimination 6 The U.S. Role in Global Tuberculosis Control 7 Mobilizing for Elimination Appendix A Statement of Task Appendix B Public Session Agendas Appendix C Site Visit Summaries Appendix D Role of Public Health Laboratories in the Control of Tuberculosis Appendix E Estimating the Number of Tuberculosis Cases That Can Be Prevented by a Program of Screening and Preventive Therapy of Newly Arrived Immigrants to the United States from Countries with a High Rate of Tuberculosis a Appendix F Approval Dates for Existing and Prospects for Development of New Antituberculosis Drugs and Vaccines Appendix G Committee Biographies Index
Executive Summary 1(12)
Fundamentals of Tuberculosis and Tuberculosis Control
13(10)
Historical Epidemiology
13(2)
Transmission and Pathogenesis of Tuberculosis
15(1)
Diagnosis and Treatment
16(3)
Principles of Tuberculosis Control
19(4)
The Current Situation and How We Got Here
23(28)
The History of Tuberculosis
23(4)
Current Status of Tuberculosis
27(12)
The Current Legal System
39(5)
The Reality of Elimination
44(2)
The Ethics of Tuberculosis Elimination
46(5)
Tuberculosis Elimination and the Changing Role of Tuberculosis Control Programs
51(35)
Recommendations
51(2)
Background
53(1)
Changes in Tuberculosis Control Program Strategies
54(5)
Crosscutting Strategies
59(23)
Conclusion
82(4)
Advancing Toward Elimination
86(36)
Recommendations
86(1)
Background and Introduction
87(1)
Treatment of Latent Tuberculosis Infection
88(1)
Current Screening for Immigrants to the United States
89(2)
The Need for Expanded Screening
91(6)
Mandatory Screening and Treatment of Latent Infection in Prisons and Other Congregate Settings
97(4)
Expanding Contact Investigations and Improving Outbreak Management
101(21)
Developing the Tools for Tuberculosis Elimination
122(27)
Recommendations
123(1)
Background and Introduction
123(1)
Current Status and Needs
124(7)
Dynamics of Tuberculosis Research
131(1)
Current Activities
132(11)
Research Priorities
143(6)
The U.S. Role in Global Tuberculosis Control
149(10)
Recommendations
149(1)
Global Context of Tuberculosis
150(2)
Global Tuberculosis Control Efforts
152(7)
Mobilizing for Elimination
159(98)
Recommendations
159(12)
APPENDIXES
A Statement of Task
171(2)
B Public Session Agendas
173(9)
C Site Visit Summaries
182(23)
D Role of Public Health Laboratories in the Control of Tuberculosis
205(29)
E Estimating the Number of Tuberculosis Cases That Can Be Prevented by a Program of Screening and Preventive Therapy of Newly Arrived Immigrants to the United States from Countries with a High Rate of Tuberculosis and the Costs of the Program
234(10)
F Approval Dates for Existing and Prospects for Development of New Antituberculosis Drugs and Vaccines
244(6)
G Committee Biographies
250(7)
Index 257


Lawrence Geiter, Editor; Committee on the Elimination of Tuberculosis in the United States, Division of Health Promotion and Disease Prevention